Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. DORM
DORM logo

DORM Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Dorman Products Inc (DORM) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
139.640
1 Day change
-0.31%
52 Week Range
166.890
Analysis Updated At
2026/07/03
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

Dorman Products (DORM) is not a strong buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The chart is constructive, but the stock is already near resistance and short-term upside looks limited. Given the lack of recent news, no strong proprietary buy signal, neutral insider/hedge fund activity, and no fresh catalyst, the better call is to hold and wait for a clearer entry rather than buy immediately.

Technical Analysis

Technically, DORM is in a bullish trend: SMA 5 is above SMA 20 and SMA 200, and MACD is positive and expanding, which supports upward momentum. However, RSI_6 at 74.733 suggests the stock is stretched in the short term even if it is labeled neutral by the source. Price at 135.55 is very close to resistance at R1 137.171 and below R2 140.738, so upside from here appears limited unless it breaks resistance cleanly. The recent pattern forecast is also mixed: slight near-term stability, modest weekly upside, but a negative monthly expectation of -3.78%. Overall, trend is bullish but entry quality is not ideal right now.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Options sentiment looks mildly bullish because the put-call open interest ratio of 0.69 is below 1, meaning call positioning is heavier than puts. That said, option volume is essentially zero today, so there is no strong fresh directional conviction from active trading. Implied volatility at 37.85 is above historical volatility 26.36, which suggests options are pricing in more uncertainty than realized movement, but the low IV rank of 10.36 indicates it is not especially elevated versus its own history. Net: mildly positive, but not a decisive bullish signal.

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
5
Buy
9

Positive Catalysts

  • ["Bullish moving average alignment: SMA_5 > SMA_20 > SMA_200", "MACD histogram is positive and expanding", "Put-call open interest ratio of 0.69 suggests more bullish than bearish positioning", "No negative news in the last week"]

Neutral/Negative Catalysts

  • ["No news in the recent week, so no fresh catalyst to drive upside", "Price is close to resistance at 137.171, limiting immediate upside", "RSI is elevated at 74.733, indicating the stock is somewhat stretched short term", "AI Stock Picker has no signal today", "SwingMax has no signal recently", "Hedge funds are neutral", "Insiders are neutral", "No recent congress trading data"]

Financial Performance

No usable financial snapshot was provided because of an error, so the latest quarter cannot be assessed directly. As a result, there is no confirmed revenue, earnings, or margin growth trend to support a long-term buy decision from fundamentals alone. The decision must therefore rely mostly on technicals, sentiment, and catalysts, which are not strong enough to justify an immediate buy.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No analyst rating or price target trend data was provided, so there is no evidence of a recent Wall Street upgrade, downgrade, or target revision to influence sentiment. Based on the available information, Wall Street appears neutral rather than strongly bullish or bearish, since there are no notable analyst catalysts and no recent news-driven re-rating. Pros: technically bullish setup and mild options optimism. Cons: no fresh catalyst, no proprietary buy signal, and price is already near resistance.

Wall Street analysts forecast DORM stock price to rise
2 Analyst Rating
Wall Street analysts forecast DORM stock price to rise
2 Buy
0 Hold
0 Sell
Moderate Buy
Current: 140.070
sliders
Low
150
Averages
165
High
180
Current: 140.070
sliders
Low
150
Averages
165
High
180
Roth Capital
Buy
downgrade
$182 -> $162
AI Analysis
2026-03-02
Reason
Roth Capital
Price Target
$182 -> $162
AI Analysis
2026-03-02
downgrade
Buy
Reason
Roth Capital lowered the firm's price target on Dorman Products to $162 from $182 and keeps a Buy rating on the shares. The company reported better than expected Q4 results but lower than expected FY26 guidance, the analyst tells investors in a research note. Light Duty demand continues to be robust, while Heavy Duty seems to have turned the corner and Specialty remains steady, the firm added.
Jefferies
Hold
to
Buy
upgrade
$159 -> $140
2026-03-02
Reason
Jefferies
Price Target
$159 -> $140
2026-03-02
upgrade
Hold
to
Buy
Reason
Jefferies upgraded Dorman Products to Buy from Hold with a price target of $140, down from $159. The firm believes the stock's recent underperformance has created an attractive entry point. The shares are trading at an historical discount after the "downbeat" Q1 guidance, despite it posting recent record margins, strong cash generation, and "clear" long-term growth visibility, the analyst tells investors in a research note.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for DORM
Unlock Now

People Also Watch